Skip to main content

A nationwide population-based study shows increasing incidence of cholangiocarcinoma

Hepatology International volume 7, pages 226–232 (2013)Cite this article

Abstract

Purpose

An increasing incidence of cholangiocarcinoma (CCA) has been reported in Western countries, but evidence is lacking in Asia. We investigated the incidence of CCA in a nationwide cohort.

Patients and methods

We conducted a nationwide cohort study based on data from the Taiwan National Health Insurance Research Database (NHIRD) between 1998 and 2008. A total of 6,491 CCA patients were recruited. Adjusted incidences, cumulative incidences, and stratified analyses were used to detect trends regarding CCA incidence in Taiwan.

Results

The incidence of CCA increased by 2.01-fold, from 1.79 in 1998 to 3.60 in 2008 per 100,000 persons. For extrahepatic CCA, the incidence increased by 1.5-fold from 0.48 to 0.73 per 100,000. Intrahepatic CCA increased by 3.0-fold from 0.72 to 2.19 per 100,000. The rising incidence of CCA was observed across all sexes and ages, especially in those older than 65 years of age. The proportion of CCA patients who underwent surgery and the overall survival rates remained stable.

Conclusions

The incidence of both intrahepatic and extrahepatic CCA increased significantly between 1998 and 2008. Rising trends were observed among different ages and sexes, especially in the elderly population.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Parkin DM, Ohshima H, Srivatanakul P, et al. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 1993;2:537–544

    PubMed  CAS  Google Scholar 

  2. Shin HR, Oh JK, Masuyer E, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010;101:579–585

    PubMed  Article  CAS  Google Scholar 

  3. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008;48:308–321

    PubMed  Article  CAS  Google Scholar 

  4. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353–1357

    PubMed  Article  CAS  Google Scholar 

  5. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004;40:472–477

    PubMed  Article  Google Scholar 

  6. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006;15:1198–1203

    PubMed  Article  Google Scholar 

  7. West J, Wood H, Logan RF, et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001. Br J Cancer 2006;94:1751–1758

    PubMed  Article  CAS  Google Scholar 

  8. Alvaro D, Crocetti E, Ferretti S, et al. Descriptive epidemiology of cholangiocarcinoma in Italy. Dig Liver Dis 2010;42:490–495

    PubMed  Article  Google Scholar 

  9. Mouzas IA, Dimoulios P, Vlachonikolis IG, et al. Increasing incidence of cholangiocarcinoma in Crete 1992–2000. Anticancer Res 2002;22:3637–3641

    PubMed  Google Scholar 

  10. Luke C, Price T, Roder D. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population. Asian Pac J Cancer Prev 2010;11:1479–1485

    PubMed  Google Scholar 

  11. Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873–875

    PubMed  Article  Google Scholar 

  12. The National Health Research Institutes of Taiwan. National Health Insurance Research Database. http://nhird.nhri.org.tw/en/

  13. Rachel Lu JF, Chiang TL. Evolution of Taiwan’s health care system. Health Econ Policy Law 2011;6:85–107

    PubMed  Article  Google Scholar 

  14. Wu CY, Wu CH, Wu MS, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol 2009;7:427–431

    PubMed  Article  Google Scholar 

  15. Wu CY, Wu MS, Kuo KN, et al. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010;28:2952–2957

    PubMed  Article  CAS  Google Scholar 

  16. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115–125

    PubMed  Article  Google Scholar 

  17. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002;17:1049–1055

    PubMed  Article  Google Scholar 

  18. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002;2:10

    PubMed  Article  Google Scholar 

  19. Gatto M, Bragazzi MC, Semeraro R, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 2010;42:253–260

    PubMed  Article  CAS  Google Scholar 

  20. Shaib YH, Davila JA, Henderson L, et al. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the United States: a population-based study. J Clin Gastroenterol 2007;41:911–917

    PubMed  Article  Google Scholar 

  21. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009;49:116–123

    PubMed  Article  Google Scholar 

  22. Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case–control study. Gastroenterology 2005;128:620–626

    PubMed  Article  Google Scholar 

  23. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173–184

    PubMed  Article  CAS  Google Scholar 

  24. Ustundag Y, Bayraktar Y. Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol 2008;14:6458–6466

    PubMed  Article  Google Scholar 

  25. Voyles CR, Smadja C, Shands WC, Blumgart LH. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg 1983;118:986–988

    PubMed  Article  CAS  Google Scholar 

  26. Lee CC, Wu CY, Chen GH. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? J Gastroenterol Hepatol 2002;17:1015–1020

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

Financial support by Taiwan National Health Research Institutes (Grant number: PH-100-PP54) and Taichung Veterans General Hospital (Grant number: TCVGH-1003303C).

Author information

Affiliations

  1. Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan

    Teng-Yu Lee

  2. Division of Gastroenterology and Hepatology, Taichung Veterans General Hospital, Taichung, Taiwan

    Teng-Yu Lee, Hsiu J. Ho, Tzu-Ting Chen & Chun-Ying Wu

  3. Department of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Teng-Yu Lee

  4. Division of Gastroenterology, National Taiwan University Hospital, Taipei, Taiwan

    Jaw-Town Lin & Ming-Shiang Wu

  5. Department of Internal Medicine, E-Da Hospital and I-Shou University, Kaohsiung, Taiwan

    Jaw-Town Lin

  6. Center for Health Policy Research and Development, National Health Research Institutes, Miaoli, Taiwan

    Jaw-Town Lin & Ken N. Kuo

  7. Faculty of Medicine, School of Medicine, National Yang-Ming University, 155, Sec. 2, Linong Street, Taipei, 112, Taiwan

    Chun-Ying Wu

  8. Department of Public Health, China Medical University, Taichung, Taiwan

    Chun-Ying Wu

  9. Department of Life Sciences, National Chung-Hsing University, Taichung, Taiwan

    Chun-Ying Wu

Authors
  1. Teng-Yu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaw-Town Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken N. Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ming-Shiang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hsiu J. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tzu-Ting Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chun-Ying Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chun-Ying Wu.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12072_2012_9369_MOESM1_ESM.pdf

Supplementary Fig. 1 The proportion of patients with overall biliary cholangiocarcinoma who received operation (OP) on the liver between 1998 and 2008. (PDF 9 kb)

12072_2012_9369_MOESM2_ESM.pdf

Supplementary Fig. 2 The 1-year, 2-year and 3-year cumulative mortality rates of patients with overall biliary cholangiocarcinoma between 1998 and 2008. (PDF 10 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, TY., Lin, JT., Kuo, K.N. et al. A nationwide population-based study shows increasing incidence of cholangiocarcinoma. Hepatol Int 7, 226–232 (2013). https://doi.org/10.1007/s12072-012-9369-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-012-9369-0

Keywords

  • Liver tumors
  • Hepatobiliary cancers
  • Epidemiology